Seeking Alpha

Regeneron Pharma EPS of $1.73, misses on revenue

  • Regeneron Pharmaceuticals (REGN): Q2 EPS of $1.73.
  • Revenue of $457.64M misses by $12.99M.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio: